Michael J. Heiferman

Michael Heiferman practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Michael Heiferman's NPI, 1336538982, was assigned on January 21, 2015. Michael Heiferman graduated from Northwestern University Feinberg Medical School in 2015. Michael Heiferman holds Illinois license 036148489.

Michael Heiferman's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Michael Heiferman's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Michael Heiferman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Heiferman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Michael Heiferman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Michael Heiferman's licenses on file in 2 states: Illinois and California.

CMS data shows 1,418 Medicare services from Michael Heiferman across 9 procedure codes in 2024, for 319 Medicare patients. Medicare paid $61,924 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Michael Heiferman in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Heiferman's median patient age at 70, with 53% women.

In 2024, Michael Heiferman wrote 130 Medicare Part D claims for 41 patients. 61% of them were for generic drugs. CMS names the drug for 71 of them, across 2 drugs with 11 or more claims each, at $1,775 in total drug cost. In 2023, CMS named 59 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Michael Heiferman for performance year 2024, reported as part of a group. Michael Heiferman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Michael Heiferman, published from 2010 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Melanoma, Tomography, Optical Coherence and Uveal Melanoma. Michael Heiferman has published most often in Biomed Opt Express. Michael Heiferman's most frequent co-authors are David Jason Bentrem, MD, Jennifer I. Lim, MD and Amani Fawzi, MD.

CMS Open Payments shows 58 general payments to Michael Heiferman from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Immunocore Limited paid the most, $3,061.

Michael Heiferman graduated from Northwestern University Feinberg Medical School in 2015.